ReviewBioMed research international2013
Actinomycetes: a repertory of green catalysts with a potential revenue resource.
Review in BioMed research international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Antiviral Activity of Polyene Macrolides Against Newcastle Disease Virus: Computational and Experimental Insights.Molecules (Basel, Switzerland) · 2026Article
- Biodegradation of lignocellulosic wastes by thermotolerant cellulolytic actinomycetal consortium isolated from Uhud Mountain, Madinah, Saudi Arabia.Biodegradation · 2025Article
- Unravelling the outcome of L-glutaminase produced by Streptomyces sp. strain 5 M as an anti-neoplasm activity.Microbial cell factories · 2025Article
- Bacillus and Streptomyces spp. as hosts for production of industrially relevant enzymes.Applied microbiology and biotechnology · 2024Review
- Use of soil actinomycetes for pharmaceutical, food, agricultural, and environmental purposes.3 Biotech · 2022Review
- Structure-Guided Engineering of a Family IV Cold-Adapted Esterase Expands Its Substrate Range.International journal of molecular sciences · 2022Article
- Identification of a novel glucuronyltransferase from Streptomyces chromofuscus ATCC 49982 for natural product glucuronidation.Applied microbiology and biotechnology · 2022Article
- Characterizing corn-straw-degrading actinomycetes and evaluating application efficiency in straw-returning experiments.Frontiers in microbiology · 2022Article
- Biodiversity of Secondary Metabolites Compounds Isolated from Phylum Actinobacteria and Its Therapeutic Applications.Molecules (Basel, Switzerland) · 2021Review
- Marine Actinomycetes, New Sources of Biotechnological Products.Marine drugs · 2021Review
- A Review on Bacterial Contribution to Lignocellulose Breakdown into Useful Bio-Products.International journal of environmental research and public health · 2021Review
- Secondary metabolites and biodiversity of actinomycetes.Journal, genetic engineering & biotechnology · 2021Review
- Molecular and Structural Characterizations of Lipases fromMarine drugs · 2021Article
- Enzyme Bioprospection of Marine-Derived Actinobacteria from the Chilean Coast and New Insight in the Mechanism of Keratin Degradation inMarine drugs · 2020Article
- Advancements in Plant and Microbe-Based Synthesis of Metallic Nanoparticles and Their Antimicrobial Activity against Plant Pathogens.Nanomaterials (Basel, Switzerland) · 2020Review
- Effect of Streptomyces probiotics on the gut microbiota of Litopenaeus vannamei challenged with Vibrio parahaemolyticus.MicrobiologyOpen · 2020Article
- Construction of a new integrating vector from actinophage ϕOZJ and its use in multiplex Streptomyces transformation.Journal of industrial microbiology & biotechnology · 2020Article
- Whole Cell Actinobacteria as Biocatalysts.Frontiers in microbiology · 2019Review
- The contribution of plant microbiota to economy growth.Microbial biotechnology · 2018Article
- Review: Engineering of thermostable enzymes for industrial applications.APL bioengineering · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biocatalysis, one of the oldest technologies, is becoming a favorable alternative to chemical processes and a vital part of green technology. It is an important revenue generating industry due to a global market projected at $7 billion in 2013 with a growth of 6.7% for enzymes alone. Some microbes are important sources of enzymes and are preferred over sources of plant and animal origin. As a result, more than 50% of the industrial enzymes are obtained from bacteria. The constant search for novel enzymes with robust characteristics has led to improvisations in the industrial processes, which is the key for profit growth. Actinomycetes constitute a significant component of the microbial population in most soils and can produce extracellular enzymes which can decompose various materials. Their enzymes are more attractive than enzymes from other sources because of their high stability and unusual substrate specificity. Actinomycetes found in extreme habitats produce novel enzymes with huge commercial potential. This review attempts to highlight the global importance of enzymes and extends to signify actinomycetes as promising harbingers of green technology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.